As a Member of the Association, I participate in activities such as networking, selection and mentoring of most promising women-led startupsAs a business angel, I selectively invest in some of them, supported in the deal making by the Association itself. Angels4Women Is a business angel community dedicated to women-led startups (seed / pre-seed / early stage), promoted by AXA Italia and Impact Hub SB

Development of Global access & reimbursement strategies for Rare DiseasesFormulating early-stage Market Access strategy for rare disease products, closely collaborating with other functions to appropriately define and plan clinical studies, regulatory approaches, and early access initiatives. Leading initiatives to understand, analyze and demonstrate the clinical, economic and social value to payers and decision-makers and developing global value pack.Supporting business development initiatives by identifying and evaluating opportunities for geographic expansion and new therapeutic indications: conducting market potential analyses and developing comprehensive business plans to drive growth and strategic positioning.

Developing comprehensive access and reimbursement strategies for Rare Diseases products in Europe and in Emerging markets. Leading initiatives to understand, analyze and demonstrate the clinical, economic and social value to payers and decision-makers and developing global value pack for the countries in scope.Working closely with Local Market Access teams to ensure Market access and pricing strategies implementation for Rare Diseases products, leading projects and closely monitoring pricing and reimbursement negotiation for Rare Disease products in the countries. Interacting closely with Rare Diseases Leadership team to develop launch strategies, tactics, and initiatives to communicate value to customers and improve market access at European level.Providing support for market access assessments for corporate development opportunities and pipeline assets acquisitions.

Development and implementation of market access strategy and tactics both at national and regional level, for the specialty portfolio, with focus for Oncology (Small molecules / Immuno-oncology / Onco-Hematology). Me and my team are point of reference for the AstraZeneca Oncology Business Unit for the Pricing & Reimbursement process, AIFA negotiations, Brand market access strategy and for partnership projects with key payers and Institutions. In particular:- We identify and evaluate market environment changes to drive proactive strategies and work closely with marketing, sales, medical and finance to formulate pricing and reimbursement plan.- We ensure identification and delivery of payer-oriented, value-based clinical & HEOR evidence generation strategies (incl. Real World Evidence) which lead to optimized access outcomes needed to support product clinical and economic value by collaborating with cross functional teams.- We work closely with Field Market access team to ensure access strategy implementation, including patient advocacy activities, building key partnership projects with external institutions and developing tools and document to support external communications.- We collaborate and support the Global pricing and Payer Evidence teams to ensure pricing policy development and value proposition strategy implementation at local level.

Development and implementation of market access strategy and tactics both at national and regional level, for current and new products. Pricing & Reimbursement strategy development & Execution:- Development of Pricing & reimbursement dossier and negotiation strategy leading a cross functional team including Medical, Regulatory, Marketing and Finance.- Working closely with the global pricing team to define pricing strategies for Italy- Analysis of macroeconomic scenario and government interventions to support internal forecast- Pricing forecast and analysis.Market access plans development and implementation:- Leading the creation of Value propositions (Health Economic model, value story, etc.). and strategic tools to ensure minimal barriers to launch and uptake of products.- Commissioning and preparation of RWE studies necessary for access and competitive messaging.- Design and implementation of partnership projects with Regional and local stakeholders, with support of the local Market access team.- Support to the Market access field on developing short term and long term market access plans and objectives among all Regions and institutions.- Development of Regional formularies dossier and publications to support Regional and local formularies inclusion.

Head of Pricing and Health economics, in charge of:- Development and implemention of P&R strategies- Dossier submissions to AIFA- Analysis of macroeconomic scenario and government interventions- Pricing forecast and analysis- Development and publication of economic evaluations (budget impact models, cost effectiveness analyses, etc.) at national and regional level

Management and development of PMA projects on:- Pricing strategies development- P&R and regional Dossiers development- Market Analysis- Mock Negotiations- MA best practice model development- Health Economics and outcome research, including development of budget impact and cost effectiveness models, retrospective database studies, etc.

Pricing and ReimbursementHealth Economics and outcome research

Economic evalution of medical devicesClinical pathways developmentReporting sistems developmentOrganisational analysis

Definition and implementation of dashboard for the evaluation of departments activities.Organizational Analysis of the Emergency DepartmentsDisease management projectCustomer satisfaction Investigation Teaching activity

Pharmaceutical research projects: database analysis, statistical elaboration, economic evaluations, drafting of reports and scientific articles.Training activities: teacher in ECM courses for physicians and pharmacists about healthcare economics and pharmacoeconomics items, decisional analysis, quality of life.

Resources planning Census and analysis of the projects implemented in the Sofala ProvinceAdministration activities